25x10 Blister

 Serratiopeptidase, an enzyme derived from the bacteria Serratia E15. It is known for its anti-inflammatory, anti-edematous, and fibrinolytic properties. Serratiopeptidase works by breaking down and eliminating inflammatory substances in the body, helping to reduce swelling and promoting a faster healing process. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that possesses analgesic, anti-inflammatory, and antipyretic properties. It works by inhibiting the production of certain chemicals in the body that are responsible for inflammation and pain. Together, the combination of Serratiopeptidase and Diclofenac Potassium in Movogesic S Tablet aims to provide a synergistic effect, offering comprehensive relief from pain and inflammation. We offer this product under the brand name Movogesic S Tablet.  

Movogesic S Tablets are indicated for the following conditions:

• Management of pain and inflammation associated with various musculoskeletal disorders
• Relief from acute episodes of pain, such as in osteoarthritis and rheumatoid arthritis
• Reduction of swelling and discomfort following surgical or traumatic procedures

Serratiopeptidase, an enzyme derived from Serratia bacteria, exerts anti-inflammatory effects by breaking down proteins, facilitating the resolution of inflammation and promoting tissue repair. Diclofenac Potassium, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the synthesis of prostaglandins, contributing to pain relief and reduced inflammation.

Absorption:

The active ingredients in Movogesic S Tablets are well-absorbed following oral administration, allowing for efficient bioavailability.

Distribution:

Serratiopeptidase and Diclofenac Potassium are distributed throughout the body, targeting areas of inflammation and pain.

 Excretion:

Serratiopeptidase undergoes minimal metabolism, primarily excreted in the urine. Diclofenac undergoes hepatic metabolism, and its metabolites are eliminated through both urine and feces.

Movogesic S Tablets are contraindicated in individuals with:

• Known hypersensitivity to Serratiopeptidase, Diclofenac, or any of the tablet's components
• History of gastrointestinal bleeding or peptic ulcers
• Severe renal or hepatic impairment

Precautions:

Before using Movogesic S Tablets, consider the following precautions:

• Caution in patients with a history of cardiovascular disease
• Monitoring of renal function in patients with pre-existing renal conditions
• Avoid use in patients with aspirin-sensitive asthma
• Use with caution in the elderly, as they may be more prone to side effects